Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06578520

1 development in the corpus

NCT06578520

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE 4 TRIAL

Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure

ClinicalTrials.gov

This is a clinical trial registry record with no results posted; it describes a planned phase IV crossover study in a small single-centre population with a surrogate renal endpoint, not yet reported.

PreliminaryDapagliflozin Fundación para la Investigación del Hospital Clínico de Valencia Heart Failure

Reported

Planned enrollment31

PhasePhase 4

Study durationaverage of 4 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support